在不同国家获得囊性纤维化治疗的差异
1Marmara University, Division of Pediatric Pulmonology, Istanbul, Turkey.
囊性纤维化调节器疗法可以提高生存率,但全球范围内的获取不平等. 解决诊断不足和卫生系统差异对于全球公平的囊性纤维化 (CF) 护理至关重要.
科学领域:
- 医学科学 医学科学 医学科学
- 肺部病理学 肺部病理学
- 遗传学 是一个遗传学.
背景情况:
- 囊性纤维化 (CF) 治疗与CFTR调节器疗法取得了重大进展.
- 这些疗法改善了许多CF患者的生存率和生活质量.
- 然而,全球获得这些改变生活的治疗方法的机会是非常不平等的.
研究的目的:
- 审查导致获得CFTR调节器疗法的全球差异的因素.
- 检查诊断,遗传,经济和卫生系统因素如何创造不平等的机会.
- 讨论新兴的战略,以实现对CFTR调节器的公平获取.
主要方法:
- 文献审查和对CFTR调节器访问现有数据的综合.
- 对影响诊断,治疗资格和治疗采用因素的分析.
- 检查全球卫生政策,定价和监管格局.
主要成果:
- 在高收入国家和低收入和中等收入国家之间,CFTR调节器的访问存在显著差异.
- 由于查和测试有限,诊断不足是不平等的主要驱动因素.
- 遗传变异的分布,成本,补偿和卫生系统能力进一步加剧了接入差距.
结论:
- 公平获得CFTR调节器需要解决诊断障碍和社会经济差异.
- 国际合作,价格差异和卫生系统的加强至关重要.
- 在诊断,经济和政策领域采取协调行动是必要的,以确保全球CF护理公平.
更多相关视频
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
07:04Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients
Published on: February 11, 2017
相关概念视频
Cystic Fibrosis: Management
Sinus disease and chronic...
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
Factors Affecting Drug Distribution: Physiological Barriers
The capillary endothelial barrier allows only smaller molecules below 600 Da (Daltons) to pass through. It also restricts drugs like heparin that are bound to blood components, limiting their movement within the bloodstream.
The...
Hepatic Drug Clearance: Role of Transporters
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
